Tolerogenic protocols for intestinal transplantation

Transplant Immunology

Volumn 13, Issue 2, 2004, Pages 131-137

  Pirenne, Jacques ^a   Kawai, Masaru ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

GVHD; Intestinal transplantation; Rejection; Tolerance

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; ENDOTOXIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGRAFT; ALLOIMMUNITY; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; COLON; DRUG TOLERABILITY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; ILEUM; IMMUNITY; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INTESTINE; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; IRRADIATION; ISCHEMIA; JEJUNUM; LARGE INTESTINE; LIVER; LIVER PROTECTION; LIVER TRANSPLANTATION; LYMPHOID TISSUE; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ORGAN TRANSPLANTATION; PERMEABILITY; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION TOLERANCE;

EID: 4544367273     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.05.005     Document Type: Article

References (71)

1. Kirkman R.L. Small bowel transplantation. Transplantation. 37(5):1984;429-433
2. Monchik G.J., Russell P.S. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery. 70:1971;693-702
3. Pirenne J., Lardinois F., D'Silva M., et al. Relevance of mesenteric lymph nodes to graft versus host disease following small bowel transplantation. Transplantation. 50:1990;711-713
4. Ingham Clark C.L., Price B.A., Malcolm P., Lear P.A., Wood R.F.M. Graft versus host disease in small bowel transplantation. Br. J. Surg. 78:1991;1077-1079
5. Baca M.E., Mowat A.McI., Mackenzie S., Parrott D.M.V. Functional characteristics of intraepithelial lymphocytes from mouse small intestine: III. Inability of intraepithelial lymphocytes to induce a systemic graft-versus-host reaction is because of failure to migrate in vivo. Gut. 28:1987;1267-1274
6. Heim L.R., McGarry M.P., Montgomery J.R., Trentin J.J., South M.A. Potentials of spleen, lymph node, and Peyer's patches to reconstitute lymphoid tissue and produce graft-versus-host reaction. Transplantation. 14(4):1972;418-423
7. Williams J.G., Pirenne J., Mayoral J.M., et al. Effect of donor pretreatment with anti-lymphocyte globulin on small bowel transplantation. Br. J. Surg. 78:1991;1176-1177
8. Browne B.J., Johnson C.P., Roza A.M., Adams M.B. Endotoxemia after small bowel transplantation. Transplant. Proc. 24(3):1992;1107
9. Price B.A., Cumberland N.S., Ingham Clark C.L., et al. Changes in small intestinal microflora following small bowel transplantation in the rat and bacterial translocation in rejection and graft-versus-host disease. Transplant. Proc. 24(3):1992;1194
10. Grant D., Hurlbut D., Zhong R., et al. Intestinal permeability and bacterial translocation following small bowel transplantation in the rat. Transplantation. 52(2):1991;221-224
11. Gifford G.E., Lohmann-Matthes M.L. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. JNCI. 78(1):1987;121-124
12. Waage A. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. Clin. Immunol. Immunopathol. 45:1987;348-355
13. Li X.C., Zhong R., Zhu L., Grant D. Donor-specific cytotoxicity induced by allogeneic intestinal epithelial cells in a sponge matrix model. Transpl. Int. 8:1995;13-19
14. Bland P. MHC class II expression by the gut epithelium. Immunol. Today. 9(6):1988;174-178
15. Matzinger P. The danger model: a renewed sense of self. Science. 296(5566):2002;301-305
16. Meijssen M.A., Heineman E., de Bruin R.W., Wolvekamp M.C., Marquet R.L., Molenaar J.C. Long-term survival of DLA-matched segmental small-bowel allografts in dogs. Transplantation. 56(5):1993;1062-1066
17. Johnsson C., Gannedahl G., Scheynius A., Tufveson G. Simultaneous occurrence of rejection and graft-versus-host reaction after allogeneic small bowel transplantation. Transplantation. 59(11):1995;1524-1529
18. Diflo T., Maki T., Balogh K., Monaco A.P. Graft-versus-host disease in fully allogeneic small bowel transplantation in the rat. Transplantation. 47(1):1989;7-11
19. Pirenne J. Contribution of large animal models to the development of clinical intestinal transplantation. Acta Gastroenterol. Belg. LXII:1999;221-225
20. Cohen Z., MacGregor A.B., Moore K.T.H., Falk R.E., Langer B., Cullen J.B. Canine small bowel transplantation. Arch. Surg. 111:1976;248-253
21. Westra A.L., Petersen A.H., Prop J., Wildevuur C.R. The combi-effect - reduced rejection of the heart by combined transplantation with the lung or spleen. Transplantation. 52(6):1991;952-955
22. Pirenne J., D'Silva M., Jacquet N. The use of spleen transplantation and cyclosporin. A treatment to ameliorate survival after small bowel transplantation. Transplant. Proc. 25:1993;1206
23. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev., Immunol. 3:2003;199-210
24. Kellersmann R., Zhong R., Garcia B., et al. A short course of high-dose cyclophosphamide induces long-term survival of intestinal allografts in mice. Transpl. Int. 14:2001;261-265
25. Nakhleh R.E., Gruessner A.C., Pirenne J., Benedetti E., Troppmann C., Gruessner R.W.G. Colon versus small bowel rejection after total bowel transplantation in a pig model. Transpl. Int. 9(Suppl. 1):1996;269-274
26. Pirenne J., Benedetti E., Gruessner A.C., et al. Combined transplantation of small and large bowel: FK506 versus cyclosporin A in a porcine model. Transplantation. 61:1996;1685-1694
27. Calne R.Y., Sells R.A., Pena J.R., et al. Induction of immunological tolerance by porcine liver allografts. Nature. 223:1969;472-476
28. Kamada N., Wight D.G.D. Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation. 38:1984;217
29. Goddard S., Pirenne J., Adams D.H. Immunological tolerance and future strategies for immunosuppression in liver transplantation. 3rd International Meeting on Therapy in Liver Diseases, Barcelona, September 22-24. 1999;197-204
30. Sarnacki S., Révillon Y., Cerf-Bensussan N., Calise D., Goulet O., Brousse N. Long-term small-bowel graft survival induced by a spontaneously tolerated liver allograft in inbred rat strains. Transplantation. 54(2):1992;383-385
31. Murase N., Demetris A.J., Kim D.G., Todo S., Fung J.J., Starzl T.E. Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery. 108(5):1990;880-889
32. Gruessner R.W., Nakhleh R.E., Benedetti E., et al. Combined liver-total bowel transplantation has no immunologic advantage over total bowel transplantation alone. A prospective study in a porcine model. Arch. Surg. 132(10):1997;1077-1085
33. Qian S., Lu L., Fu F., et al. Apoptosis within spontaneously accepted mouse liver allografts. Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J. Immunol. 158:1997;4654-4661
34. Meyer D., Baumgardt S., Loeffeler S., et al. Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction. Transplantation. 66(11):1998;1530-1536
35. Yin D.P., Sankary H.N., Talor-Edwards C., et al. Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Transplantation. 66(1):1998;1-5
36. Koshiba T., Van Damme B., Ji P., et al. Intestinal allografts delay rejection and prolong survival of combined donor-specific and third party solid organ transplant. Transplant. Proc. 33:2001;1550-1552
37. Wekerle T., Sykes M. Mixed chimerism as an approach for the induction of transplantation tolerance. Transplantation. 68(4):1999;459-467
38. Sykes S., Sachs D.H. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol. Today. 9(1):1988;23-27
39. Orloff S.L., Yin Q., Corless C.L., Orloff M.S., Rabkin J.M., Wagner C.R. Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection. Transplantation. 69:2000;1295-1303
40. Starzl T.E., Murase N., Thomson A., Demetris A.J. Liver transplants contribute to their own success. Nat. Med. 2(2):1996;163-165
41. Starzl T.E., Demetris A.J., Rao A.S., et al. Spontaneous and iatrogenically augmented leukocyte chimerism in organ transplant recipients. Transplant. Proc. 26(5):1994;3071-3076
42. Wood K., Sachs D.H. Chimerism and transplantation tolerance: cause and effect. Immunol. Today. 17:1996;584-587
43. Pirenne J., Benedetti E., Gruessner A.C., et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. Surgery. 121:1997;79-88
44. Gruessner R.W., Nakhleh R.E., Harmon J.V., Dunning M., Gruessner A.C. Donor-specific portal blood transfusion in intestinal transplantation: a prospective, preclinical large animal study. Transplantation. 66(2):1998;164-169
45. Gruessner R.W., Levay-Young B.K., Nakhleh R.E., et al. Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation. Transplantation. 2004;. [in press]
46. Pruvot F.R., Navarro F., Janin A., et al. Characterization, quantification, and localization of passenger T lymphocytes and NK cells in human liver before transplantation. Transpl. Int. 8:1995;273-279
47. Navarro F., Portalès P., Candon S., et al. Natural killer cell and αβ and γδ lymphocyte traffic into the liver graft immediately after liver transplantation. Transplantation. 69(4):2000;633-639
48. Shaffer D., Diflo T., Love W., Clowes G.H., Maki T., Monaco A.P. Immunologic and metabolic effects of caval versus portal venous drainage in small-bowel transplantation. Surgery. 104(3):1988;518-524
49. Schraut W.H. Current status of small-bowel transplantation. Gastroenterology. 94:1988;525-538
50. Abu-Elmagd K., Reyes J., Todo S., et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J. Am. Coll. Surg. 186:1998;512-527
51. Sindhi R., Fox I.J., Heffron T., Shaw B.W., Langnas A.N. Procurement and preparation of human isolated small intestinal grafts for transplantation. Transplantation. 60(8):1995;771-773
52. Fortner J.G. Intestinal transplantation. Slavin S. Bone marrow and organ transplantation. 1984;411-415 Elsevier Science Publishers
53. Langnas A., Iyer K. Liver and small bowel transplantation. Maddrey W.C., Schiff E.R., Sorrell M.F. Transplantation of the liver. 2001;111-119 Lippincott Williams and Wilkins, Philadelphia
54. Todo S., Tzakis A., Reyes J., et al. Small intestinal transplantation in humans with or without the colon. Transplantation. 57(6):1994;840-848
55. Berney T., Kato T., Nishida S., et al. Portal versus systemic drainage of small bowel allografts: comparative assessment of survival, function, rejection, and bacterial translocation. J. Am. Coll. Surg. 195(6):2002;804-813
56. Gruessner A.C., Sutherland D.E., Gruessner R.W. Matching in pancreas transplantation - a registry analysis. Transplant. Proc. 33(1-2):2001;1665-1666
57. Lee R.G., Nakamura K., Tsamandas A.C., et al. Pathology of human intestinal transplantation. Gastroenterology. 110:1996;1820-1834
58. Casavilla S.A., Selby R., Abu-Elmagd K., et al. Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin. Transplant. 8:1994;49-53
59. Holterman M.J., Holterman A.L., Carrol R., et al. Living-related bowel transplantation to treat short bowel syndrome in a four-year-old child: a case report. Pediatr. Surg. 38(12):2003;1763-1765
60. Abu-Elmagd K., Reyes J., Bond G., et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann. Surg. 234(3):2001;404-416
61. Grant D., Wall W., Mimeault R., et al. Successful small-bowel/liver transplantation. Lancet. 335:1990;181-184
62. Olausson M., Mjornstedt L., Norden G., et al. Auxiliary liver and combined kidney transplantation prevents hyperacute kidney rejection in highly sensitized patients. Transplant. Proc. 34(8):2002;3106-3107
63. Abu-Elmagd K., Todo S., Tzakis A., et al. Three years clinical experience with intestinal transplantation. J. Am. Coll. Surg. 179(4):1994;385-400
64. Sharland A., Yan Y., Wang C., et al. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance. Transplantation. 68(11):1999;1736-1745
65. Yamada K., Gianello P.R., Ierino F.L., et al. Role of the thymus in transplantation tolerance in miniature swine: II. Effect of steroids and age of the induction of tolerance to class I mismatched renal allografts. Transplantation. 67(3):1999;458-467
66. Lan F., Hayamizu K., Strober S. Cyclosporine facilitates chimeric and inhibits nonchimeric tolerance after posttransplant total lymphoid irradiation. Transplantation. 69(4):2000;649-655
67. Opelz G. for the Collaborative Transplant Study Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Transplantation. 60(11):1995;1220-1224
68. Koshiba T., Kitade H., Waer M., Mathieu C., Van Damme B., Pirenne J. Break of tolerance via donor-specific blood transfusion by high doses of steroids: a differential effect after intestinal transplantation and heart transplantation. Transplant. Proc. 35(8):2003;3153-3155
69. Furtado G.C., Curotto de Lafaille M.A., Kutchukhidze N., Lafaille J.J. Interleukin 2 signaling is required for CD4+ regulatory T cell function. J. Exp. Med. 196(6):2002;851-857
70. Starzl T.E., Murase N., Abu-Elmagd K., et al. Tolerogenic immunosuppression for organ transplantation. Lancet. 361:2003;1502-1510
71. Pirenne J., Koshiba T., Geboes K., et al. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression. Transplantation. 73(6):2002;966-968